Pharma & Healthcare
Global Daratumumab Injection Market Research Report 2025
- Sep 24, 25
- ID: 518636
- Pages: 71
- Figures: 68
- Views: 3
Report Scope
This report aims to provide a comprehensive presentation of the global market for Daratumumab Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Daratumumab Injection.
The Daratumumab Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Daratumumab Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, by Technology and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Daratumumab Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Technology and by regions.
By Company
Johnson & Johnson
Henlius Biotech
Chia Tai Tianqing Pharmaceutical Group
Hangzhou Jiuyuan Gene Engineering
CSPC Pharmaceutical Group Limited
Segment by Type
100mg/5ml/Bottle
400mg/20ml/Bottle
Segment by Technology
Original Drug
Generic Drugs
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Daratumumab Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Daratumumab Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for Daratumumab Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Daratumumab Injection.
The Daratumumab Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Daratumumab Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, by Technology and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Daratumumab Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Technology and by regions.
By Company
Johnson & Johnson
Henlius Biotech
Chia Tai Tianqing Pharmaceutical Group
Hangzhou Jiuyuan Gene Engineering
CSPC Pharmaceutical Group Limited
Segment by Type
100mg/5ml/Bottle
400mg/20ml/Bottle
Segment by Technology
Original Drug
Generic Drugs
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Daratumumab Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Daratumumab Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Daratumumab Injection Market Overview
1.1 Product Definition
1.2 Daratumumab Injection by Type
1.2.1 Global Daratumumab Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 100mg/5ml/Bottle
1.2.3 400mg/20ml/Bottle
1.3 Daratumumab Injection by Technology
1.3.1 Global Daratumumab Injection Market Value Comparison by Technology: 2024 VS 2031
1.3.2 Original Drug
1.3.3 Generic Drugs
1.4 Daratumumab Injection by Application
1.4.1 Global Daratumumab Injection Market Value by Application (2024 VS 2031)
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Daratumumab Injection Market Size Estimates and Forecasts
1.5.1 Global Daratumumab Injection Revenue 2020-2031
1.5.2 Global Daratumumab Injection Sales 2020-2031
1.5.3 Global Daratumumab Injection Market Average Price (2020-2031)
1.6 Assumptions and Limitations
2 Daratumumab Injection Market Competition by Manufacturers
2.1 Global Daratumumab Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Daratumumab Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Daratumumab Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Daratumumab Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Daratumumab Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Daratumumab Injection, Product Type & Application
2.7 Global Key Manufacturers of Daratumumab Injection, Date of Enter into This Industry
2.8 Global Daratumumab Injection Market Competitive Situation and Trends
2.8.1 Global Daratumumab Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Daratumumab Injection Players Market Share by Revenue
2.8.3 Global Daratumumab Injection Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Daratumumab Injection Market Scenario by Region
3.1 Global Daratumumab Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Daratumumab Injection Sales by Region: 2020-2031
3.2.1 Global Daratumumab Injection Sales by Region: 2020-2025
3.2.2 Global Daratumumab Injection Sales by Region: 2026-2031
3.3 Global Daratumumab Injection Revenue by Region: 2020-2031
3.3.1 Global Daratumumab Injection Revenue by Region: 2020-2025
3.3.2 Global Daratumumab Injection Revenue by Region: 2026-2031
3.4 North America Daratumumab Injection Market Facts & Figures by Country
3.4.1 North America Daratumumab Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Daratumumab Injection Sales by Country (2020-2031)
3.4.3 North America Daratumumab Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Daratumumab Injection Market Facts & Figures by Country
3.5.1 Europe Daratumumab Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Daratumumab Injection Sales by Country (2020-2031)
3.5.3 Europe Daratumumab Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Daratumumab Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Daratumumab Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Daratumumab Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Daratumumab Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Daratumumab Injection Market Facts & Figures by Country
3.7.1 Latin America Daratumumab Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Daratumumab Injection Sales by Country (2020-2031)
3.7.3 Latin America Daratumumab Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Daratumumab Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Daratumumab Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Daratumumab Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Daratumumab Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Daratumumab Injection Sales by Type (2020-2031)
4.1.1 Global Daratumumab Injection Sales by Type (2020-2025)
4.1.2 Global Daratumumab Injection Sales by Type (2026-2031)
4.1.3 Global Daratumumab Injection Sales Market Share by Type (2020-2031)
4.2 Global Daratumumab Injection Revenue by Type (2020-2031)
4.2.1 Global Daratumumab Injection Revenue by Type (2020-2025)
4.2.2 Global Daratumumab Injection Revenue by Type (2026-2031)
4.2.3 Global Daratumumab Injection Revenue Market Share by Type (2020-2031)
4.3 Global Daratumumab Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Daratumumab Injection Sales by Application (2020-2031)
5.1.1 Global Daratumumab Injection Sales by Application (2020-2025)
5.1.2 Global Daratumumab Injection Sales by Application (2026-2031)
5.1.3 Global Daratumumab Injection Sales Market Share by Application (2020-2031)
5.2 Global Daratumumab Injection Revenue by Application (2020-2031)
5.2.1 Global Daratumumab Injection Revenue by Application (2020-2025)
5.2.2 Global Daratumumab Injection Revenue by Application (2026-2031)
5.2.3 Global Daratumumab Injection Revenue Market Share by Application (2020-2031)
5.3 Global Daratumumab Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Company Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Daratumumab Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Johnson & Johnson Daratumumab Injection Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Henlius Biotech
6.2.1 Henlius Biotech Company Information
6.2.2 Henlius Biotech Description and Business Overview
6.2.3 Henlius Biotech Daratumumab Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Henlius Biotech Daratumumab Injection Product Portfolio
6.2.5 Henlius Biotech Recent Developments/Updates
6.3 Chia Tai Tianqing Pharmaceutical Group
6.3.1 Chia Tai Tianqing Pharmaceutical Group Company Information
6.3.2 Chia Tai Tianqing Pharmaceutical Group Description and Business Overview
6.3.3 Chia Tai Tianqing Pharmaceutical Group Daratumumab Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Chia Tai Tianqing Pharmaceutical Group Daratumumab Injection Product Portfolio
6.3.5 Chia Tai Tianqing Pharmaceutical Group Recent Developments/Updates
6.4 Hangzhou Jiuyuan Gene Engineering
6.4.1 Hangzhou Jiuyuan Gene Engineering Company Information
6.4.2 Hangzhou Jiuyuan Gene Engineering Description and Business Overview
6.4.3 Hangzhou Jiuyuan Gene Engineering Daratumumab Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Hangzhou Jiuyuan Gene Engineering Daratumumab Injection Product Portfolio
6.4.5 Hangzhou Jiuyuan Gene Engineering Recent Developments/Updates
6.5 CSPC Pharmaceutical Group Limited
6.5.1 CSPC Pharmaceutical Group Limited Company Information
6.5.2 CSPC Pharmaceutical Group Limited Description and Business Overview
6.5.3 CSPC Pharmaceutical Group Limited Daratumumab Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 CSPC Pharmaceutical Group Limited Daratumumab Injection Product Portfolio
6.5.5 CSPC Pharmaceutical Group Limited Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Daratumumab Injection Industry Chain Analysis
7.2 Daratumumab Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Daratumumab Injection Production Mode & Process Analysis
7.4 Daratumumab Injection Sales and Marketing
7.4.1 Daratumumab Injection Sales Channels
7.4.2 Daratumumab Injection Distributors
7.5 Daratumumab Injection Customer Analysis
8 Daratumumab Injection Market Dynamics
8.1 Daratumumab Injection Industry Trends
8.2 Daratumumab Injection Market Drivers
8.3 Daratumumab Injection Market Challenges
8.4 Daratumumab Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Daratumumab Injection by Type
1.2.1 Global Daratumumab Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 100mg/5ml/Bottle
1.2.3 400mg/20ml/Bottle
1.3 Daratumumab Injection by Technology
1.3.1 Global Daratumumab Injection Market Value Comparison by Technology: 2024 VS 2031
1.3.2 Original Drug
1.3.3 Generic Drugs
1.4 Daratumumab Injection by Application
1.4.1 Global Daratumumab Injection Market Value by Application (2024 VS 2031)
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Daratumumab Injection Market Size Estimates and Forecasts
1.5.1 Global Daratumumab Injection Revenue 2020-2031
1.5.2 Global Daratumumab Injection Sales 2020-2031
1.5.3 Global Daratumumab Injection Market Average Price (2020-2031)
1.6 Assumptions and Limitations
2 Daratumumab Injection Market Competition by Manufacturers
2.1 Global Daratumumab Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Daratumumab Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Daratumumab Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Daratumumab Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Daratumumab Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Daratumumab Injection, Product Type & Application
2.7 Global Key Manufacturers of Daratumumab Injection, Date of Enter into This Industry
2.8 Global Daratumumab Injection Market Competitive Situation and Trends
2.8.1 Global Daratumumab Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Daratumumab Injection Players Market Share by Revenue
2.8.3 Global Daratumumab Injection Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Daratumumab Injection Market Scenario by Region
3.1 Global Daratumumab Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Daratumumab Injection Sales by Region: 2020-2031
3.2.1 Global Daratumumab Injection Sales by Region: 2020-2025
3.2.2 Global Daratumumab Injection Sales by Region: 2026-2031
3.3 Global Daratumumab Injection Revenue by Region: 2020-2031
3.3.1 Global Daratumumab Injection Revenue by Region: 2020-2025
3.3.2 Global Daratumumab Injection Revenue by Region: 2026-2031
3.4 North America Daratumumab Injection Market Facts & Figures by Country
3.4.1 North America Daratumumab Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Daratumumab Injection Sales by Country (2020-2031)
3.4.3 North America Daratumumab Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Daratumumab Injection Market Facts & Figures by Country
3.5.1 Europe Daratumumab Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Daratumumab Injection Sales by Country (2020-2031)
3.5.3 Europe Daratumumab Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Daratumumab Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Daratumumab Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Daratumumab Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Daratumumab Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Daratumumab Injection Market Facts & Figures by Country
3.7.1 Latin America Daratumumab Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Daratumumab Injection Sales by Country (2020-2031)
3.7.3 Latin America Daratumumab Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Daratumumab Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Daratumumab Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Daratumumab Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Daratumumab Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Daratumumab Injection Sales by Type (2020-2031)
4.1.1 Global Daratumumab Injection Sales by Type (2020-2025)
4.1.2 Global Daratumumab Injection Sales by Type (2026-2031)
4.1.3 Global Daratumumab Injection Sales Market Share by Type (2020-2031)
4.2 Global Daratumumab Injection Revenue by Type (2020-2031)
4.2.1 Global Daratumumab Injection Revenue by Type (2020-2025)
4.2.2 Global Daratumumab Injection Revenue by Type (2026-2031)
4.2.3 Global Daratumumab Injection Revenue Market Share by Type (2020-2031)
4.3 Global Daratumumab Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Daratumumab Injection Sales by Application (2020-2031)
5.1.1 Global Daratumumab Injection Sales by Application (2020-2025)
5.1.2 Global Daratumumab Injection Sales by Application (2026-2031)
5.1.3 Global Daratumumab Injection Sales Market Share by Application (2020-2031)
5.2 Global Daratumumab Injection Revenue by Application (2020-2031)
5.2.1 Global Daratumumab Injection Revenue by Application (2020-2025)
5.2.2 Global Daratumumab Injection Revenue by Application (2026-2031)
5.2.3 Global Daratumumab Injection Revenue Market Share by Application (2020-2031)
5.3 Global Daratumumab Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Company Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Daratumumab Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Johnson & Johnson Daratumumab Injection Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Henlius Biotech
6.2.1 Henlius Biotech Company Information
6.2.2 Henlius Biotech Description and Business Overview
6.2.3 Henlius Biotech Daratumumab Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Henlius Biotech Daratumumab Injection Product Portfolio
6.2.5 Henlius Biotech Recent Developments/Updates
6.3 Chia Tai Tianqing Pharmaceutical Group
6.3.1 Chia Tai Tianqing Pharmaceutical Group Company Information
6.3.2 Chia Tai Tianqing Pharmaceutical Group Description and Business Overview
6.3.3 Chia Tai Tianqing Pharmaceutical Group Daratumumab Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Chia Tai Tianqing Pharmaceutical Group Daratumumab Injection Product Portfolio
6.3.5 Chia Tai Tianqing Pharmaceutical Group Recent Developments/Updates
6.4 Hangzhou Jiuyuan Gene Engineering
6.4.1 Hangzhou Jiuyuan Gene Engineering Company Information
6.4.2 Hangzhou Jiuyuan Gene Engineering Description and Business Overview
6.4.3 Hangzhou Jiuyuan Gene Engineering Daratumumab Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Hangzhou Jiuyuan Gene Engineering Daratumumab Injection Product Portfolio
6.4.5 Hangzhou Jiuyuan Gene Engineering Recent Developments/Updates
6.5 CSPC Pharmaceutical Group Limited
6.5.1 CSPC Pharmaceutical Group Limited Company Information
6.5.2 CSPC Pharmaceutical Group Limited Description and Business Overview
6.5.3 CSPC Pharmaceutical Group Limited Daratumumab Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 CSPC Pharmaceutical Group Limited Daratumumab Injection Product Portfolio
6.5.5 CSPC Pharmaceutical Group Limited Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Daratumumab Injection Industry Chain Analysis
7.2 Daratumumab Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Daratumumab Injection Production Mode & Process Analysis
7.4 Daratumumab Injection Sales and Marketing
7.4.1 Daratumumab Injection Sales Channels
7.4.2 Daratumumab Injection Distributors
7.5 Daratumumab Injection Customer Analysis
8 Daratumumab Injection Market Dynamics
8.1 Daratumumab Injection Industry Trends
8.2 Daratumumab Injection Market Drivers
8.3 Daratumumab Injection Market Challenges
8.4 Daratumumab Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Daratumumab Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Daratumumab Injection Market Value by Technology, (US$ Million) & (2024 VS 2031)
Table 3. Global Daratumumab Injection Market Value by Application (2024 VS 2031) & (US$ Million)
Table 4. Global Daratumumab Injection Market Competitive Situation by Manufacturers in 2024
Table 5. Global Daratumumab Injection Sales (K Units) of Key Manufacturers (2020-2025)
Table 6. Global Daratumumab Injection Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Daratumumab Injection Revenue (US$ Million) by Manufacturers (2020-2025)
Table 8. Global Daratumumab Injection Revenue Share by Manufacturers (2020-2025)
Table 9. Global Market Daratumumab Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 10. Global Key Players of Daratumumab Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 11. Global Key Manufacturers of Daratumumab Injection, Manufacturing Sites & Headquarters
Table 12. Global Key Manufacturers of Daratumumab Injection, Product Type & Application
Table 13. Global Key Manufacturers of Daratumumab Injection, Date of Enter into This Industry
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Daratumumab Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Daratumumab Injection as of 2024)
Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 17. Global Daratumumab Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 18. Global Daratumumab Injection Sales by Region (2020-2025) & (K Units)
Table 19. Global Daratumumab Injection Sales Market Share by Region (2020-2025)
Table 20. Global Daratumumab Injection Sales by Region (2026-2031) & (K Units)
Table 21. Global Daratumumab Injection Sales Market Share by Region (2026-2031)
Table 22. Global Daratumumab Injection Revenue by Region (2020-2025) & (US$ Million)
Table 23. Global Daratumumab Injection Revenue Market Share by Region (2020-2025)
Table 24. Global Daratumumab Injection Revenue by Region (2026-2031) & (US$ Million)
Table 25. Global Daratumumab Injection Revenue Market Share by Region (2026-2031)
Table 26. North America Daratumumab Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 27. North America Daratumumab Injection Sales by Country (2020-2025) & (K Units)
Table 28. North America Daratumumab Injection Sales by Country (2026-2031) & (K Units)
Table 29. North America Daratumumab Injection Revenue by Country (2020-2025) & (US$ Million)
Table 30. North America Daratumumab Injection Revenue by Country (2026-2031) & (US$ Million)
Table 31. Europe Daratumumab Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 32. Europe Daratumumab Injection Sales by Country (2020-2025) & (K Units)
Table 33. Europe Daratumumab Injection Sales by Country (2026-2031) & (K Units)
Table 34. Europe Daratumumab Injection Revenue by Country (2020-2025) & (US$ Million)
Table 35. Europe Daratumumab Injection Revenue by Country (2026-2031) & (US$ Million)
Table 36. Asia Pacific Daratumumab Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 37. Asia Pacific Daratumumab Injection Sales by Region (2020-2025) & (K Units)
Table 38. Asia Pacific Daratumumab Injection Sales by Region (2026-2031) & (K Units)
Table 39. Asia Pacific Daratumumab Injection Revenue by Region (2020-2025) & (US$ Million)
Table 40. Asia Pacific Daratumumab Injection Revenue by Region (2026-2031) & (US$ Million)
Table 41. Latin America Daratumumab Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 42. Latin America Daratumumab Injection Sales by Country (2020-2025) & (K Units)
Table 43. Latin America Daratumumab Injection Sales by Country (2026-2031) & (K Units)
Table 44. Latin America Daratumumab Injection Revenue by Country (2020-2025) & (US$ Million)
Table 45. Latin America Daratumumab Injection Revenue by Country (2026-2031) & (US$ Million)
Table 46. Middle East and Africa Daratumumab Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 47. Middle East and Africa Daratumumab Injection Sales by Country (2020-2025) & (K Units)
Table 48. Middle East and Africa Daratumumab Injection Sales by Country (2026-2031) & (K Units)
Table 49. Middle East and Africa Daratumumab Injection Revenue by Country (2020-2025) & (US$ Million)
Table 50. Middle East and Africa Daratumumab Injection Revenue by Country (2026-2031) & (US$ Million)
Table 51. Global Daratumumab Injection Sales (K Units) by Type (2020-2025)
Table 52. Global Daratumumab Injection Sales (K Units) by Type (2026-2031)
Table 53. Global Daratumumab Injection Sales Market Share by Type (2020-2025)
Table 54. Global Daratumumab Injection Sales Market Share by Type (2026-2031)
Table 55. Global Daratumumab Injection Revenue (US$ Million) by Type (2020-2025)
Table 56. Global Daratumumab Injection Revenue (US$ Million) by Type (2026-2031)
Table 57. Global Daratumumab Injection Revenue Market Share by Type (2020-2025)
Table 58. Global Daratumumab Injection Revenue Market Share by Type (2026-2031)
Table 59. Global Daratumumab Injection Price (US$/Unit) by Type (2020-2025)
Table 60. Global Daratumumab Injection Price (US$/Unit) by Type (2026-2031)
Table 61. Global Daratumumab Injection Sales (K Units) by Application (2020-2025)
Table 62. Global Daratumumab Injection Sales (K Units) by Application (2026-2031)
Table 63. Global Daratumumab Injection Sales Market Share by Application (2020-2025)
Table 64. Global Daratumumab Injection Sales Market Share by Application (2026-2031)
Table 65. Global Daratumumab Injection Revenue (US$ Million) by Application (2020-2025)
Table 66. Global Daratumumab Injection Revenue (US$ Million) by Application (2026-2031)
Table 67. Global Daratumumab Injection Revenue Market Share by Application (2020-2025)
Table 68. Global Daratumumab Injection Revenue Market Share by Application (2026-2031)
Table 69. Global Daratumumab Injection Price (US$/Unit) by Application (2020-2025)
Table 70. Global Daratumumab Injection Price (US$/Unit) by Application (2026-2031)
Table 71. Johnson & Johnson Company Information
Table 72. Johnson & Johnson Description and Business Overview
Table 73. Johnson & Johnson Daratumumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 74. Johnson & Johnson Daratumumab Injection Product
Table 75. Johnson & Johnson Recent Developments/Updates
Table 76. Henlius Biotech Company Information
Table 77. Henlius Biotech Description and Business Overview
Table 78. Henlius Biotech Daratumumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 79. Henlius Biotech Daratumumab Injection Product
Table 80. Henlius Biotech Recent Developments/Updates
Table 81. Chia Tai Tianqing Pharmaceutical Group Company Information
Table 82. Chia Tai Tianqing Pharmaceutical Group Description and Business Overview
Table 83. Chia Tai Tianqing Pharmaceutical Group Daratumumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 84. Chia Tai Tianqing Pharmaceutical Group Daratumumab Injection Product
Table 85. Chia Tai Tianqing Pharmaceutical Group Recent Developments/Updates
Table 86. Hangzhou Jiuyuan Gene Engineering Company Information
Table 87. Hangzhou Jiuyuan Gene Engineering Description and Business Overview
Table 88. Hangzhou Jiuyuan Gene Engineering Daratumumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 89. Hangzhou Jiuyuan Gene Engineering Daratumumab Injection Product
Table 90. Hangzhou Jiuyuan Gene Engineering Recent Developments/Updates
Table 91. CSPC Pharmaceutical Group Limited Company Information
Table 92. CSPC Pharmaceutical Group Limited Description and Business Overview
Table 93. CSPC Pharmaceutical Group Limited Daratumumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 94. CSPC Pharmaceutical Group Limited Daratumumab Injection Product
Table 95. CSPC Pharmaceutical Group Limited Recent Developments/Updates
Table 96. Key Raw Materials Lists
Table 97. Raw Materials Key Suppliers Lists
Table 98. Daratumumab Injection Distributors List
Table 99. Daratumumab Injection Customers List
Table 100. Daratumumab Injection Market Trends
Table 101. Daratumumab Injection Market Drivers
Table 102. Daratumumab Injection Market Challenges
Table 103. Daratumumab Injection Market Restraints
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
Table 107. Authors List of This Report
List of Figures
Figure 1. Product Picture of Daratumumab Injection
Figure 2. Global Daratumumab Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Daratumumab Injection Market Share by Type: 2024 & 2031
Figure 4. 100mg/5ml/Bottle Product Picture
Figure 5. 400mg/20ml/Bottle Product Picture
Figure 6. Global Daratumumab Injection Market Value by Technology, (US$ Million) & (2020-2031)
Figure 7. Global Daratumumab Injection Market Share by Technology: 2024 VS 2031
Figure 8. Original Drug Product Picture
Figure 9. Generic Drugs Product Picture
Figure 10. Global Daratumumab Injection Market Value by Application (2020-2031) & (US$ Million)
Figure 11. Global Daratumumab Injection Market Share by Application: 2024 & 2031
Figure 12. Hospital
Figure 13. Clinic
Figure 14. Global Daratumumab Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Daratumumab Injection Market Size (2020-2031) & (US$ Million)
Figure 16. Global Daratumumab Injection Sales (2020-2031) & (K Units)
Figure 17. Global Daratumumab Injection Average Price (US$/Unit) & (2020-2031)
Figure 18. Daratumumab Injection Report Years Considered
Figure 19. Daratumumab Injection Sales Share by Manufacturers in 2024
Figure 20. Global Daratumumab Injection Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest Daratumumab Injection Players: Market Share by Revenue in Daratumumab Injection in 2024
Figure 22. Daratumumab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global Daratumumab Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America Daratumumab Injection Sales Market Share by Country (2020-2031)
Figure 25. North America Daratumumab Injection Revenue Market Share by Country (2020-2031)
Figure 26. United States Daratumumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Daratumumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Daratumumab Injection Sales Market Share by Country (2020-2031)
Figure 29. Europe Daratumumab Injection Revenue Market Share by Country (2020-2031)
Figure 30. Germany Daratumumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Daratumumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Daratumumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Daratumumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Daratumumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Daratumumab Injection Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Daratumumab Injection Revenue Market Share by Region (2020-2031)
Figure 37. China Daratumumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Daratumumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Daratumumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Daratumumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Daratumumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan Daratumumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Southeast Asia Daratumumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Daratumumab Injection Sales Market Share by Country (2020-2031)
Figure 45. Latin America Daratumumab Injection Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Daratumumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Daratumumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Daratumumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Colombia Daratumumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Daratumumab Injection Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Daratumumab Injection Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Daratumumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Daratumumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Daratumumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Daratumumab Injection by Type (2020-2031)
Figure 56. Global Revenue Market Share of Daratumumab Injection by Type (2020-2031)
Figure 57. Global Daratumumab Injection Price (US$/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Daratumumab Injection by Application (2020-2031)
Figure 59. Global Revenue Market Share of Daratumumab Injection by Application (2020-2031)
Figure 60. Global Daratumumab Injection Price (US$/Unit) by Application (2020-2031)
Figure 61. Daratumumab Injection Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Daratumumab Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Daratumumab Injection Market Value by Technology, (US$ Million) & (2024 VS 2031)
Table 3. Global Daratumumab Injection Market Value by Application (2024 VS 2031) & (US$ Million)
Table 4. Global Daratumumab Injection Market Competitive Situation by Manufacturers in 2024
Table 5. Global Daratumumab Injection Sales (K Units) of Key Manufacturers (2020-2025)
Table 6. Global Daratumumab Injection Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Daratumumab Injection Revenue (US$ Million) by Manufacturers (2020-2025)
Table 8. Global Daratumumab Injection Revenue Share by Manufacturers (2020-2025)
Table 9. Global Market Daratumumab Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 10. Global Key Players of Daratumumab Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 11. Global Key Manufacturers of Daratumumab Injection, Manufacturing Sites & Headquarters
Table 12. Global Key Manufacturers of Daratumumab Injection, Product Type & Application
Table 13. Global Key Manufacturers of Daratumumab Injection, Date of Enter into This Industry
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Daratumumab Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Daratumumab Injection as of 2024)
Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 17. Global Daratumumab Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 18. Global Daratumumab Injection Sales by Region (2020-2025) & (K Units)
Table 19. Global Daratumumab Injection Sales Market Share by Region (2020-2025)
Table 20. Global Daratumumab Injection Sales by Region (2026-2031) & (K Units)
Table 21. Global Daratumumab Injection Sales Market Share by Region (2026-2031)
Table 22. Global Daratumumab Injection Revenue by Region (2020-2025) & (US$ Million)
Table 23. Global Daratumumab Injection Revenue Market Share by Region (2020-2025)
Table 24. Global Daratumumab Injection Revenue by Region (2026-2031) & (US$ Million)
Table 25. Global Daratumumab Injection Revenue Market Share by Region (2026-2031)
Table 26. North America Daratumumab Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 27. North America Daratumumab Injection Sales by Country (2020-2025) & (K Units)
Table 28. North America Daratumumab Injection Sales by Country (2026-2031) & (K Units)
Table 29. North America Daratumumab Injection Revenue by Country (2020-2025) & (US$ Million)
Table 30. North America Daratumumab Injection Revenue by Country (2026-2031) & (US$ Million)
Table 31. Europe Daratumumab Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 32. Europe Daratumumab Injection Sales by Country (2020-2025) & (K Units)
Table 33. Europe Daratumumab Injection Sales by Country (2026-2031) & (K Units)
Table 34. Europe Daratumumab Injection Revenue by Country (2020-2025) & (US$ Million)
Table 35. Europe Daratumumab Injection Revenue by Country (2026-2031) & (US$ Million)
Table 36. Asia Pacific Daratumumab Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 37. Asia Pacific Daratumumab Injection Sales by Region (2020-2025) & (K Units)
Table 38. Asia Pacific Daratumumab Injection Sales by Region (2026-2031) & (K Units)
Table 39. Asia Pacific Daratumumab Injection Revenue by Region (2020-2025) & (US$ Million)
Table 40. Asia Pacific Daratumumab Injection Revenue by Region (2026-2031) & (US$ Million)
Table 41. Latin America Daratumumab Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 42. Latin America Daratumumab Injection Sales by Country (2020-2025) & (K Units)
Table 43. Latin America Daratumumab Injection Sales by Country (2026-2031) & (K Units)
Table 44. Latin America Daratumumab Injection Revenue by Country (2020-2025) & (US$ Million)
Table 45. Latin America Daratumumab Injection Revenue by Country (2026-2031) & (US$ Million)
Table 46. Middle East and Africa Daratumumab Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 47. Middle East and Africa Daratumumab Injection Sales by Country (2020-2025) & (K Units)
Table 48. Middle East and Africa Daratumumab Injection Sales by Country (2026-2031) & (K Units)
Table 49. Middle East and Africa Daratumumab Injection Revenue by Country (2020-2025) & (US$ Million)
Table 50. Middle East and Africa Daratumumab Injection Revenue by Country (2026-2031) & (US$ Million)
Table 51. Global Daratumumab Injection Sales (K Units) by Type (2020-2025)
Table 52. Global Daratumumab Injection Sales (K Units) by Type (2026-2031)
Table 53. Global Daratumumab Injection Sales Market Share by Type (2020-2025)
Table 54. Global Daratumumab Injection Sales Market Share by Type (2026-2031)
Table 55. Global Daratumumab Injection Revenue (US$ Million) by Type (2020-2025)
Table 56. Global Daratumumab Injection Revenue (US$ Million) by Type (2026-2031)
Table 57. Global Daratumumab Injection Revenue Market Share by Type (2020-2025)
Table 58. Global Daratumumab Injection Revenue Market Share by Type (2026-2031)
Table 59. Global Daratumumab Injection Price (US$/Unit) by Type (2020-2025)
Table 60. Global Daratumumab Injection Price (US$/Unit) by Type (2026-2031)
Table 61. Global Daratumumab Injection Sales (K Units) by Application (2020-2025)
Table 62. Global Daratumumab Injection Sales (K Units) by Application (2026-2031)
Table 63. Global Daratumumab Injection Sales Market Share by Application (2020-2025)
Table 64. Global Daratumumab Injection Sales Market Share by Application (2026-2031)
Table 65. Global Daratumumab Injection Revenue (US$ Million) by Application (2020-2025)
Table 66. Global Daratumumab Injection Revenue (US$ Million) by Application (2026-2031)
Table 67. Global Daratumumab Injection Revenue Market Share by Application (2020-2025)
Table 68. Global Daratumumab Injection Revenue Market Share by Application (2026-2031)
Table 69. Global Daratumumab Injection Price (US$/Unit) by Application (2020-2025)
Table 70. Global Daratumumab Injection Price (US$/Unit) by Application (2026-2031)
Table 71. Johnson & Johnson Company Information
Table 72. Johnson & Johnson Description and Business Overview
Table 73. Johnson & Johnson Daratumumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 74. Johnson & Johnson Daratumumab Injection Product
Table 75. Johnson & Johnson Recent Developments/Updates
Table 76. Henlius Biotech Company Information
Table 77. Henlius Biotech Description and Business Overview
Table 78. Henlius Biotech Daratumumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 79. Henlius Biotech Daratumumab Injection Product
Table 80. Henlius Biotech Recent Developments/Updates
Table 81. Chia Tai Tianqing Pharmaceutical Group Company Information
Table 82. Chia Tai Tianqing Pharmaceutical Group Description and Business Overview
Table 83. Chia Tai Tianqing Pharmaceutical Group Daratumumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 84. Chia Tai Tianqing Pharmaceutical Group Daratumumab Injection Product
Table 85. Chia Tai Tianqing Pharmaceutical Group Recent Developments/Updates
Table 86. Hangzhou Jiuyuan Gene Engineering Company Information
Table 87. Hangzhou Jiuyuan Gene Engineering Description and Business Overview
Table 88. Hangzhou Jiuyuan Gene Engineering Daratumumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 89. Hangzhou Jiuyuan Gene Engineering Daratumumab Injection Product
Table 90. Hangzhou Jiuyuan Gene Engineering Recent Developments/Updates
Table 91. CSPC Pharmaceutical Group Limited Company Information
Table 92. CSPC Pharmaceutical Group Limited Description and Business Overview
Table 93. CSPC Pharmaceutical Group Limited Daratumumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 94. CSPC Pharmaceutical Group Limited Daratumumab Injection Product
Table 95. CSPC Pharmaceutical Group Limited Recent Developments/Updates
Table 96. Key Raw Materials Lists
Table 97. Raw Materials Key Suppliers Lists
Table 98. Daratumumab Injection Distributors List
Table 99. Daratumumab Injection Customers List
Table 100. Daratumumab Injection Market Trends
Table 101. Daratumumab Injection Market Drivers
Table 102. Daratumumab Injection Market Challenges
Table 103. Daratumumab Injection Market Restraints
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
Table 107. Authors List of This Report
List of Figures
Figure 1. Product Picture of Daratumumab Injection
Figure 2. Global Daratumumab Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Daratumumab Injection Market Share by Type: 2024 & 2031
Figure 4. 100mg/5ml/Bottle Product Picture
Figure 5. 400mg/20ml/Bottle Product Picture
Figure 6. Global Daratumumab Injection Market Value by Technology, (US$ Million) & (2020-2031)
Figure 7. Global Daratumumab Injection Market Share by Technology: 2024 VS 2031
Figure 8. Original Drug Product Picture
Figure 9. Generic Drugs Product Picture
Figure 10. Global Daratumumab Injection Market Value by Application (2020-2031) & (US$ Million)
Figure 11. Global Daratumumab Injection Market Share by Application: 2024 & 2031
Figure 12. Hospital
Figure 13. Clinic
Figure 14. Global Daratumumab Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Daratumumab Injection Market Size (2020-2031) & (US$ Million)
Figure 16. Global Daratumumab Injection Sales (2020-2031) & (K Units)
Figure 17. Global Daratumumab Injection Average Price (US$/Unit) & (2020-2031)
Figure 18. Daratumumab Injection Report Years Considered
Figure 19. Daratumumab Injection Sales Share by Manufacturers in 2024
Figure 20. Global Daratumumab Injection Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest Daratumumab Injection Players: Market Share by Revenue in Daratumumab Injection in 2024
Figure 22. Daratumumab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global Daratumumab Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America Daratumumab Injection Sales Market Share by Country (2020-2031)
Figure 25. North America Daratumumab Injection Revenue Market Share by Country (2020-2031)
Figure 26. United States Daratumumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Daratumumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Daratumumab Injection Sales Market Share by Country (2020-2031)
Figure 29. Europe Daratumumab Injection Revenue Market Share by Country (2020-2031)
Figure 30. Germany Daratumumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Daratumumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Daratumumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Daratumumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Daratumumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Daratumumab Injection Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Daratumumab Injection Revenue Market Share by Region (2020-2031)
Figure 37. China Daratumumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Daratumumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Daratumumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Daratumumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Daratumumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan Daratumumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Southeast Asia Daratumumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Daratumumab Injection Sales Market Share by Country (2020-2031)
Figure 45. Latin America Daratumumab Injection Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Daratumumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Daratumumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Daratumumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Colombia Daratumumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Daratumumab Injection Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Daratumumab Injection Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Daratumumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Daratumumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Daratumumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Daratumumab Injection by Type (2020-2031)
Figure 56. Global Revenue Market Share of Daratumumab Injection by Type (2020-2031)
Figure 57. Global Daratumumab Injection Price (US$/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Daratumumab Injection by Application (2020-2031)
Figure 59. Global Revenue Market Share of Daratumumab Injection by Application (2020-2031)
Figure 60. Global Daratumumab Injection Price (US$/Unit) by Application (2020-2031)
Figure 61. Daratumumab Injection Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Spatial Metabolomics Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 04, 25
Global Pharmaceutical Process Analytical Technology (PAT) Software Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 04, 25
Global HASE Rheology Modifiers Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 04, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232